Investor's Business Daily on MSN1h
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
Amgen stock rose early Wednesday, though the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...
GSK lifts long-term sales targets on new drug pipeline
As a result, the company said it is targeting total sales of more than £40 billion by 2031, hiking its previous target of ...
Half of adults don’t realize that taking this over-the-counter drug daily is super risky
About 800,000 Americans will have a heart attack or stroke this year. While heart disease can affect anyone, the risk substantially rises with age.
Why Merck (MRK) Is Plunging Today
MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...